CULT Food Science Corp files third patent application for cultured meat enriched with cholesterol-lowering supplements

CULT Food Science Corp said it filed its third provisional patent application on June 17, 2022, for the production of cultured meat enriched with dietary supplements or additives that help lower consumers’ cholesterol levels.

The investment platform with a focus on cellular agriculture said it is also continuing to develop its own intellectual property (IP) in the form of patents and other intangible assets in order to produce food for human consumption directly from cells.

“Not only does cellular agriculture have the potential to enhance certain nutrition levels in consumers but it also has the ability to provide food to people all over the world who are experiencing shortages of key foods,” CULT CEO Lejjy Gafour said in a statement.

“Filing the Third Patent Application is yet another step in the right direction for CULT as it pursues the development of its own valuable IP,” he added.

READ: CULT Food Science says its Umami Meats portfolio company wins recognition and makes significant operational progress

CULT said the topic of increasing food production from cells is timely given that the global food system has been weakened by COVID-19, climate change, energy shock and the invasion of Ukraine by Russia, two countries which account for 12% of the world’s traded calories.

The company noted a warning by UN Secretary-General António Guterres on May 18. 2022, that the coming months threaten “the specter of a global food shortage” that could last for years.

“The high cost of staple foods has already raised the number of people who cannot be sure of getting enough to eat by 440 million to 1.6 billion. Therefore, CULT’s management has deemed it critical to develop its own IP and deploy capital to help accelerate the commercialization of cellular agriculture,” the company said.

In addition, the ability to not only produce cultured meat but increase its nutritional value could be invaluable to CULT and the broader cellular agriculture industry.

For that reason, CULT said its third patent application explores the creation of a cultured meat product that tastes and feels like traditional meat but with lower cholesterol content than traditional meat since cultured meat too can have cholesterol that increases the risk of contracting certain types of chronic disease.

“Helping to ease the global food insecurity crisis is a major priority for us at CULT and we believe that investing in a diverse array of cellular agriculture opportunities, both directly and indirectly, while continuing to file innovative patent applications, will help achieve that goal and stabilize the world’s food supply as its population continues to grow,” added Gafour.

The first-of-its-kind in North America, CULT provides investors with unprecedented exposure to the most innovative start-up, private and early stage cultivated meat, cultured dairy and cell-based foods companies around the world.

Contact the author at jon.hopkins@proactiveinvestors.com

Leave a Comment